Akebia Therapeutics to Report First Quarter 2019 Financial Results

08:00 EDT 30 Apr 2019 | Businesswire
This article has expired, however you can still download the PDF.
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for patients with kidney disease, today announced plans to release its financial resul...

Other Sources for this Article

Investor Contact
Kristen K. Sheppard, Esq


More From BioPortfolio on "Akebia Therapeutics to Report First Quarter 2019 Financial Results"

Quick Search

Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...